Latest News

September 22, 2019
A recent Peer Exchange series from The American Journal of Managed Care® brought together a panel of experts to discuss spinal muscular atrophy (SMA), including its clinical presentation, diagnosis of its various types, and the potential of new disease-modifying treatments. The panel was moderated by Peter L. Salgo, MD.
 
September 21, 2019
New research coming from Doximity is adding to the literature on the physician shortage's impact on maternity care, identifying which metropolitan areas are most likely to suffer from a shortage of obstetricians and gynecologists (OB/GYNs) in coming years.
 
September 21, 2019
Patients who reported feeling lonely had worse health ratings, 6-minute walk tests, and breathlessness.
September 21, 2019
Measurement of drug levels early in treatment with ustekinumab for patients with psoriasis may be able to successfully predict patient response and, therefore, direct a treatment strategy.
September 21, 2019
Researchers investigated current evidence linking genetic variation to deep brain stimulation treatment and outcomes in Parkinson disease (PD), finding a promising development where genetic profiling may be important for clinicians to personalize medical and surgical therapy for patients.
September 21, 2019
Flavored e-cigarettes without nicotine were shown to have differing asthma outcomes on mice based on the flavor, indicating that some flavors may worsen the severity of allergic airways disease, according to a new study.
September 21, 2019
A recent literature review suggests a new clinical pathway for children presenting with headache in the emergency department. 
September 20, 2019
A link between a genetic risk score (GRS) related to chronic obstructive pulmonary disease (COPD) susceptibility and computed tomagraphy (CT) lung structure was found, indicating the possible use of lung structure data to determine COPD risk, according to a new study.
September 20, 2019
Psoriasis is known to be linked with metabolic syndrome, which is triggered by chronic inflammation and fosters obesity and dyslipidemia. A recent study looked at another chronic inflammatory skin disease, lichen planus, to better understand any associations with metabolic syndrome.
September 20, 2019
Novo Nordisk officials believe the new therapy will fufill an unmet need for patients with type 2 diabetes and obesity who need a GLP-1 receptor agonist but do not wish to use an injectable drug.
Copyright AJMC 2006-2019 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.